Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.015 USD | -1.72% | -10.00% | -3.31% |
04-19 | Lifecore Biomedical Gets Nasdaq Warning Over Delayed Quarterly Report | MT |
04-01 | Lifecore Biomedical, Inc. Provides Revenue Guidance for Full Year Fiscal 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.31% | 187M | |
+31.37% | 588B | |
-2.79% | 364B | |
+20.45% | 326B | |
+5.45% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.80% | 167B | |
+0.14% | 161B |
- Stock Market
- Equities
- LFCR Stock
- News Lifecore Biomedical, Inc.
- Landec : Roth Capital Adjusts Landec's Price Target to $14 from $15, Keeps Buy Rating